Viking Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-15.76-14.37-17.4146.21
Price/Sales ratio
2.45K50.1015.273.44
Earnings per Share (EPS)
$-1.54$-1.69$-1.40$0.52

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.57-0.92-1.31-5.12-19.96-22.38-11.33-6.57-10.71-20.44-19.73-19.96
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-1.552.482.407.831.472.081.671.754.965.039.351.47
Price/Cash Flow ratio
-21.66-2.48-1.74-7.14-23.48-23.31-18.76-7.46-14.92-23.92-28.08-23.31
Price/Free Cash Flow ratio
-21.66-2.48-1.74-7.14-23.48-23.31-18.76-7.46-14.92-23.92-28.08-23.31
Price/Earnings Growth ratio
-0.000.030.010.410.384.25-0.29-0.16-0.41-5.991.020.38
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-2.87%-4.19%-13.22%-9.00%12.29%-27.12%8.72%1.79%2.16%N/AN/A-27.12%
Return on Assets
-719.13%-151.58%-101.34%-93.02%-7.29%-9.06%-14.05%-25.63%-39.98%-23.31%-40.86%-9.06%
Return On Equity
98.89%-268.24%-183.16%-152.82%-7.40%-9.30%-14.75%-26.74%-46.36%-24.65%-42.76%-9.30%
Return on Capital Employed
120.50%-89.11%-171.82%-141.62%-8.78%-11.78%-17.45%-27.58%-47.99%-28.86%-47.99%-11.78%
Liquidity Ratios
Current Ratio
N/A7.682.152.5266.4041.8321.11N/AN/AN/A7.6141.83
Quick Ratio
0.037.682.152.5266.4041.8321.1123.987.6119.197.0841.83
Cash ratio
0.030.380.471.035.441.232.403.001.662.901.661.23
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/A3.41K5.25K1.78K10.69K9.39KN/A3.41K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.510.130.220.15N/A0.000.000.000.000.000.130.13
Debt Equity Ratio
-0.070.240.400.25N/A0.000.000.000.000.000.150.15
Long-term Debt to Capitalization
-0.060.19N/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
-0.070.190.280.20N/A0.000.000.000.000.000.010.01
Interest Coverage Ratio
N/A-12.21-7.65-14.86-64.75N/AN/AN/AN/AN/A-87.28N/A
Cash Flow to Debt Ratio
-1.01-4.05-3.38-4.27N/A-81.96-65.99-1.64K-159.20-226.46-30.94-30.94
Company Equity Multiplier
-0.131.761.801.641.011.021.041.041.151.051.151.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111111111111
Cash Flow Coverage Ratio
-1.01-4.05-3.38-4.27N/A-81.96-65.99-1.64K-159.20-226.46-30.94-30.94
Short Term Coverage Ratio
-5.23N/A-3.38-4.27N/A-81.96-65.99-1.64K-159.20-226.46-159.20-81.96
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A